A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice
Susanne Rebers(The Netherlands Cancer Institute), Marjanka K. Schmidt(University of Cambridge), Margreet Jonker(Spaarne Gasthuis), Ron A. Tupker(St. Antonius Ziekenhuis), Michiel W. M. van den Brekel(Oncode Institute), Robert A. de Leeuw(Amsterdam UMC Location Vrije Universiteit Amsterdam), Willem Jan W. Bos(St. Antonius Ziekenhuis), Eric Vermeulen(The Netherlands Cancer Institute), F.E. van Leeuwen(The Netherlands Cancer Institute), Jan C. Grutters(St. Antonius Ziekenhuis), Victor J. Verwaal(The Netherlands Cancer Institute), Jules H. Schagen van Leeuwen(Holy Family Hospital), Biljana Zupan‐Kajcovski(The Netherlands Cancer Institute), Neil K. Aaronson(The Netherlands Cancer Institute), Remco de Bree(Utrecht University), Alexander Brandenburg(The Netherlands Cancer Institute), Richard M. Brohet(The Netherlands Cancer Institute), C. Bax(Amsterdam UMC Location Vrije Universiteit Amsterdam), Willemien J. van Driel(The Netherlands Cancer Institute), T.J. Stoof(Amsterdam UMC Location Vrije Universiteit Amsterdam), Leon G. J. M. Plusjé(Rode Kruis Ziekenhuis)
Cited by 8
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k